nafamostat and ovalbumin

nafamostat has been researched along with ovalbumin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, M; Akatsu, H; Katsuragi, T; Okada, H; Sakata, N; Shibata, K; Shimizu, N	1
Inagaki, N; Ishizaki, M; Kajiwara, D; Nagai, H; Tanaka, H; Toyohara, T; Wakahara, K	1

Other Studies

2 other study(ies) available for nafamostat and ovalbumin

Article	Year
Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. Journal of immunology (Baltimore, Md. : 1950), 2001, Oct-15, Volume: 167, Issue:8 Topics: Airway Resistance; Animals; Antigens; Antigens, CD; Asthma; Benzamidines; Bronchi; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Chemokines, CC; Chemokines, CXC; Chemotactic Factors; Complement C3a; Complement C5a; Complement C5a, des-Arginine; Cytokines; Growth Substances; Guanidines; Hypersensitivity; Intercellular Signaling Peptides and Proteins; Lung; Membrane Proteins; Ovalbumin; Rats; Receptor, Anaphylatoxin C5a; Receptors, Complement; Receptors, Complement 3b; RNA, Messenger	2001
Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma. Journal of pharmacological sciences, 2008, Volume: 108, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Benzamidines; Bronchoalveolar Lavage Fluid; Chemokines; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Goblet Cells; Guanidines; Hyperplasia; Immunoglobulin E; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Serine Proteinase Inhibitors; Tryptases	2008

Article

Year

Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.

Journal of immunology (Baltimore, Md. : 1950), 2001, Oct-15, Volume: 167, Issue:8

Topics: Airway Resistance; Animals; Antigens; Antigens, CD; Asthma; Benzamidines; Bronchi; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Chemokines, CC; Chemokines, CXC; Chemotactic Factors; Complement C3a; Complement C5a; Complement C5a, des-Arginine; Cytokines; Growth Substances; Guanidines; Hypersensitivity; Intercellular Signaling Peptides and Proteins; Lung; Membrane Proteins; Ovalbumin; Rats; Receptor, Anaphylatoxin C5a; Receptors, Complement; Receptors, Complement 3b; RNA, Messenger

2001

Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma.

Journal of pharmacological sciences, 2008, Volume: 108, Issue:3

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Benzamidines; Bronchoalveolar Lavage Fluid; Chemokines; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Goblet Cells; Guanidines; Hyperplasia; Immunoglobulin E; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Serine Proteinase Inhibitors; Tryptases

2008